Free Trial

Tilray Brands (NASDAQ:TLRY) Earns Neutral Rating from Zelman & Associates

Tilray Brands logo with Medical background

Key Points

  • Zelman & Associates has reissued a "neutral" rating for Tilray Brands (NASDAQ:TLRY), with a consensus target price of $1.92.
  • Tilray's stock saw a recent decline in price targets, with Piper Sandler lowering theirs from $2.00 to $1.00 and multiple analysts giving it ratings ranging from "strong sell" to "buy."
  • Institutional ownership of Tilray Brands stands at 9.35%, with significant increases in holdings noted from firms such as JPMorgan Chase & Co. and WINTON GROUP Ltd.
  • MarketBeat previews top five stocks to own in August.
  • Limited Time Offer: Unlock powerful research tools, advanced financial data, and expert insights to help you invest with confidence. Save 50% when you upgrade to MarketBeat All Access during the month of July. Claim your discount here.

Tilray Brands (NASDAQ:TLRY - Get Free Report)'s stock had its "neutral" rating reissued by Zelman & Associates in a note issued to investors on Tuesday,Benzinga reports.

A number of other analysts also recently weighed in on the stock. Piper Sandler reduced their price target on shares of Tilray Brands from $2.00 to $1.00 and set a "neutral" rating for the company in a report on Wednesday, April 9th. Wall Street Zen lowered Tilray Brands to a "strong sell" rating in a research note on Saturday, July 5th. Finally, Roth Capital reiterated a "neutral" rating on shares of Tilray Brands in a research report on Monday, April 14th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $1.92.

Read Our Latest Report on Tilray Brands

Tilray Brands Stock Up 1.6%

TLRY opened at $0.70 on Tuesday. Tilray Brands has a twelve month low of $0.35 and a twelve month high of $2.15. The business has a 50 day moving average price of $0.49 and a 200 day moving average price of $0.64. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.61 and a current ratio of 2.62. The firm has a market cap of $704.25 million, a P/E ratio of -0.67 and a beta of 1.82.

Institutional Trading of Tilray Brands

Several institutional investors have recently bought and sold shares of TLRY. Raymond James Financial Inc. acquired a new position in Tilray Brands in the fourth quarter valued at about $255,000. Teacher Retirement System of Texas acquired a new position in Tilray Brands in the fourth quarter worth $211,000. WINTON GROUP Ltd increased its stake in shares of Tilray Brands by 46.4% in the fourth quarter. WINTON GROUP Ltd now owns 88,401 shares of the company's stock valued at $118,000 after buying an additional 28,008 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Tilray Brands by 112.7% in the fourth quarter. JPMorgan Chase & Co. now owns 919,082 shares of the company's stock valued at $1,222,000 after buying an additional 487,051 shares during the last quarter. Finally, OLD Mission Capital LLC lifted its position in Tilray Brands by 23.0% during the 4th quarter. OLD Mission Capital LLC now owns 205,164 shares of the company's stock worth $273,000 after buying an additional 38,305 shares in the last quarter. Institutional investors and hedge funds own 9.35% of the company's stock.

About Tilray Brands

(Get Free Report)

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.

Featured Stories

Analyst Recommendations for Tilray Brands (NASDAQ:TLRY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Tilray Brands Right Now?

Before you consider Tilray Brands, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.

While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ALERT: Big Tech Earnings – Watch Before Wednesday
ACT FAST! Congress is Dumping these 3 Stocks
3 “Boring” Mega Cap Stocks to Turn Into Pure Profit

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines